Quarterly ResultMay 11, 2026, 04:33 PM
STERIS Fiscal 2026 Revenue +9%; EPS $7.93; Board Approves $1B Buyback
AI Summary
STERIS plc announced strong financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026, marking another record year. Full year revenue from continuing operations increased 9% to $5.9 billion, with adjusted diluted EPS rising to $10.17. The company's Board of Directors also approved a new $1 billion share repurchase program. Looking ahead, STERIS anticipates fiscal 2027 revenue to increase 7-8% and adjusted diluted EPS to be in the range of $11.10 to $11.30.
Key Highlights
- Board approved a new $1 billion share repurchase program.
- Full year fiscal 2026 revenue from continuing operations increased 9% to $5.9 billion.
- Full year fiscal 2026 adjusted diluted EPS from continuing operations increased to $10.17.
- Fourth quarter fiscal 2026 revenue from continuing operations increased 7% to $1.6 billion.
- Fourth quarter fiscal 2026 adjusted diluted EPS was $2.83.
- Fiscal 2027 revenue is expected to increase 7-8%.
- Fiscal 2027 adjusted diluted EPS is anticipated to be $11.10 to $11.30.
- Fiscal 2026 free cash flow was $982.9 million, up from $787.2 million.